Arrowhead Pharmaceuticals Inc. buy Piper Sandler
Start price
13.01.26
/
50%
€58.38
Target price
13.01.27
€94.35
Performance (%)
1.44%
Price
22.01.26
€59.22
Summary
This prediction is currently active. The BUY prediction by Piper_Sandler shows slight gains of 1.44%. This prediction currently runs until 13.01.27. The prediction end date can be changed by Piper_Sandler at any time. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Arrowhead Pharmaceuticals Inc. | 2.191% |
| iShares Core DAX® | -1.933% |
| iShares Nasdaq 100 | -0.972% |
| iShares Nikkei 225® | -2.056% |
| iShares S&P 500 | -1.185% |
Comments by Piper_Sandler for this prediction
In the thread Arrowhead Pharmaceuticals Inc. diskutieren
Arrowhead Pharmaceuticals (NASDAQ:ARWR) had its "overweight" rating reaffirmed by analysts at Piper Sandler. They now have a $110.00 price target on the stock, up previously from $100.00.
Ratings data for ARWR provided by MarketBeat
Stopped prediction by Piper_Sandler for Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€55.98
17.12.25
17.12.25
€85.13
17.12.26
17.12.26
5.79%
22.01.26
22.01.26
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€34.14
19.11.25
19.11.25
€60.47
19.11.26
19.11.26
73.46%
22.01.26
22.01.26
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€25.00
27.11.24
27.11.24
€42.54
27.11.25
27.11.25
100.00%
28.11.25
28.11.25
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€16.42
08.10.24
08.10.24
€56.53
08.10.25
08.10.25
91.78%
09.10.25
09.10.25